1. Home
  2. DSS vs ONCO Comparison

DSS vs ONCO Comparison

Compare DSS & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DSS Inc.

DSS

DSS Inc.

HOLD

Current Price

$0.70

Market Cap

7.0M

ML Signal

HOLD

Logo Onconetix Inc.

ONCO

Onconetix Inc.

HOLD

Current Price

$1.12

Market Cap

3.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DSS
ONCO
Founded
1984
2018
Country
United States
United States
Employees
102
N/A
Industry
Containers/Packaging
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0M
3.0M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
DSS
ONCO
Price
$0.70
$1.12
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 5.4M
2.0M
Earning Date
05-15-2026
06-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 42.45
22.80
EPS
N/A
★ N/A
Revenue
★ $2,085,000.00
$815,371.00
Revenue This Year
$1.21
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.36
$0.09
52 Week High
$1.86
$6.73

Technical Indicators

Market Signals
Indicator
DSS
ONCO
Relative Strength Index (RSI) 55.13 70.96
Support Level $0.50 $0.62
Resistance Level $1.05 $1.18
Average True Range (ATR) 0.07 0.13
MACD -0.01 0.04
Stochastic Oscillator 21.32 62.02

Price Performance

Historical Comparison
DSS
ONCO

About DSS DSS Inc.

DSS Inc is operating a business focused on four operating segments: Product Packaging, Biotechnology, Commercial Lending, and Securities and Investment Management. Currently operates five distinct business lines that operate around the globe with primary operations in North America and Asia. Product packaging manufactures and sells sophisticated custom folding cartons, mailers, photo sleeves, and complex three-dimensional direct mail solutions. The biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the Securities and Investment Management.

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.

Share on Social Networks: